Skip to content

FAQs for Patients Related to COVID-19

December 16, 2020

COVID-19 Vaccine and Pregnancy/Breastfeeding

Although preventive measures (universal masking, physical distancing, hand hygiene, and prompt testing with isolation and contact tracing) can significantly decrease the transmission of the virus that causes COVID-19 illness, the consensus among experts is that only an effective COVID-19 vaccine will end the pandemic. Despite the categorization of pregnancy as a high-risk condition for severe COVID-19 illness, hospitalization, and mortality, pregnancy remains an exclusion for participation in vaccine trials. There was no biological reason for exclusion of pregnant or lactating patients from these trials.

At UCSF, in alignment with the American College of Obstetrics and Gynecology, the Society for Maternal Fetal Medicine and the American Society for Reproductive Medicine, we recommend that pregnant patients and patients who are actively trying to conceive have access to COVID-19 vaccines, and that they and their healthcare professional engage in shared decision-making regarding receipt of the vaccine. Counseling should balance available data on vaccine safety, risks to pregnant patients from SARS-CoV-2 infection, and an individual's risk for infection and severe disease. mRNA vaccines, which are the first vaccines available, do not contain a live virus but rather induce humoral and cellular immune response through the use of viral mRNA. The theoretical risk of fetal harm from mRNA vaccines is very low.

If you are actively trying to conceive and are eligible for the vaccine, there is no reason to delay pregnancy attempts or fertility treatment because of vaccine administration or to defer treatment until the second dose has been administered. Patients who conceive in the window between the first and second dose of the vaccine should be offered the second dose of the vaccine at the appropriate interval.

May 7, 2020

Note: The COVID-19 pandemic is rapidly evolving, with new information every day. The above information is subject to change on this basis. Please check back and speak with your provider for the most up-to-date information.

Please contact us via with additional questions you would like to appear on this page. We are here and we are listening.

If you wish to speak to your primary doctor further about any of the above, please don’t hesitate to reach out to your Care Team directly.

April 16, 2020

FAQs for Patients Related to COVID-19

Presented by ASRM and SART

We understand that it can be devastating for those who have been trying to build their families to now have to delay treatment due to COVID-19. The goal of this communication is to help give patients a clearer understanding of the ASRM COVID-19 Task Force recommendations, and to help answer questions they may have.

Sources | |

American Society for Reproductive Medicine

409 12th Street S.W. Washington, D.C 20024

Tel (205)978-5000|